Skip to main content

Table 2 Baseline Demographics

From: A randomized, controlled, single-blinded, multicenter evaluation of the efficacy and safety of a once weekly two dose otic gel containing florfenicol, terbinafine and betamethasone administered for the treatment of canine otitis externa

Demographic Otic Gel Otic Suspension P-value
Age in years (mean ± SD) 6.2 ± 3.8 5.8 ± 3.7 0.46
Number of Male/Female (%) 55/45 53/47 0.72
Weight in kg (mean ± SD) 21.9 ± 14.4 22.8 ± 14.8 0.62
Bilateral otitis 103 (70%) 101 (74%) 0.51
Ceruminous exudate 108 (73%) 96 (70%) 0.60
Purulent exudate 40 (27%) 41 (30%)
Acute/subchronic/chronic 42 (28%), 87 (59%), 19 (13%) 30 (22%), 90 (66%), 17 (12%) 0.42
Number of days since onset (mean ± SD) 18.8 ± 22.8 18.6 ± 22.5 0.73
Previously treated 13 (9%) 17 (12%) 0.34
Recurrent 46 (31%) 46 (34%) 0.90
Culture yeast only (%) 25 27 0.89
Culture bacteria only (%) 22 20
Culture yeasts and bacteria (%) 39 42